FAZIELLE ENTWICKLUNG DES PRAEKAMBRIUMS ZWISCHEN SERRA MINEIRA UND SERRA DO CABRAL (SUEDWESTLICHE ESPINHACO-ZONE, MINAS GERAIS, BRASILIEN). = EVOLUTION DES FACIES DU PRECAMBRIEN ENTRE LA SERRA MINEIRA ET LA SERRA DO CABRAL, ZONE SUD-OUEST D'ESPINHACO, MINAS GERAIS, BRESILWALDE D.1976; ; S.L.; DA. 1976; PP. 1-62; H.T. 8; BIBL. 12 P.; 23 ILL.; 1 CART.; (DISS. GEOWISS. FAK.; FREIBURG I. BR.)Thesis

NEUE HINWEISE FUER EINE PROTEROZOISCHE VEREISUNG IN OSTBRASILIEN. = NOUVELLES PREUVES D'UNE GLACIATION PROTEROZOIQUE AU BRESIL ORIENTALWALDE D.1976; MUENSTER. FORSCH. GEOL. PALAEONTOL.; DTSCH.; DA. 1976; NO 38-39; PP. 47-59; ABS. ANGL. PORT.; BIBL. 1 P.; 5 ILL.Article

Die fazielle Entwicklung des Proterozoikums in Urucum-District, Mato Grosso, Brasilien = L'évolution des faciès du Protérozoïque dans le district d'Urucum, Mato Grosso, BrésilLEONARDOS, O. H; WALDE, D. H. G.Geowissenschaftliches Lateinamerika Kolloquium. 8. 1982, 56Conference Paper

The Fe-Mn ore deposits of Urucum, Brazil: an oxygen isotope study = Gisements de fer-manganèse de Urucum, Brésil: étude des isotopes de l'oxygèneHOEFS, J; MÜLLER, G; SCHUSTER, K. A et al.Chemical geology. 1987, Vol 65, Num 3-4, pp 311-319, issn 0009-2541, no spécialConference Paper

Stratigraphy and mineralogy of manganese ores of Urucum, Mato Grosso, Brazil = Stratigraphie et minéralogie des gisements de manganèse d'Urucum, Mato Grosso, BrésilWALDE, D. H. G; GIERTH, E; LEONARDOS, O. H et al.Geologische Rundschau (1910. Print). 1981, Vol 70, Num 3, pp 1077-1085, issn 0016-7835Article

Rivizor - A new third-generation aromatase inhibitor for the treatment of advanced breast cancer after tamoxifen failureGOSS, P. E; WALDE, D; DE COSTER, R et al.Oncology. 1999, Vol 56, Num 2, pp 114-121, issn 0030-2414Article

A phase II study of menogaril in low-grade non-hodgkin's lymphoma : an NCI Canada clinical trials group studySKILLINGS, J; CRIPPS, C; EISENHAUER, E et al.Investigational new drugs. 1991, Vol 9, Num 1, pp 79-82, issn 0167-6997, 4 p.Article

A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodesFINDLAY, B; TONKIN, K; LEVINE, M et al.Annals of oncology. 2007, Vol 18, Num 10, pp 1646-1651, issn 0923-7534, 6 p.Article

Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24GOODWIN, R; DING, K; WALDE, D et al.Annals of oncology. 2010, Vol 21, Num 11, pp 2220-2226, issn 0923-7534, 7 p.Article

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer : An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology GroupMURRAY, N; LIVINGSTON, R. B; TURRISI, A et al.Journal of clinical oncology. 1999, Vol 17, Num 8, pp 2300-2308, issn 0732-183XArticle

The role of the 5-HT₃ antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapyPATER, J. L; LOFTERS, W. S; NAVARI, R et al.Annals of oncology. 1997, Vol 8, Num 2, pp 181-185, issn 0923-7534Article

Phase III double-blind comparison of dolasetron mesylate and ondansetron and an evaluation of the additive role of dexamethasone in the prevention of acute and delayed nausea and vomiting due to moderately emetogenic chemotherapyLOFTERS, W. S; PATER, J. L; NAVARI, R et al.Journal of clinical oncology. 1997, Vol 15, Num 8, pp 2966-2973, issn 0732-183XArticle

Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapyLATREILLE, J; PATER, J; WILLIAMS, C et al.Journal of clinical oncology. 1998, Vol 16, Num 3, pp 1174-1178, issn 0732-183XArticle